Wave's pivotal trial, Dr. William Abraham is working on another heart failure trial as the new CMO at Cardiac Dimensions.
In today’s ACT Brief, we explore how real-world data can improve protocol design and feasibility, highlight new findings from ...
Existing frameworks for explainable artificial intelligence (XAI) and AI governance, such as the EU AI Act and the NIST AI ...
The DESTINY-Breast11 trial showed in patients with high-risk HER2-positive early breast cancer that the ADC followed by ...
As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...
"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...
NYU Langone’s Center for Multisite Studies is led by experts who are experienced in managing and supporting research.
Through a five-year, $10.7 million National Institutes of Health grant awarded to Boise State University and co-led with ...
The termination of thousands of federal grants that fund clinical trials threatens to reverse substantial progress in understanding and treating the health challenges of marginalized populations, ...
Design Therapeutics, Inc. (($DSGN)) announced an update on their ongoing clinical study. Study Overview: Design Therapeutics, Inc. is conducting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback